文献速递妇科

IB1期宫颈癌根治性子宫切除术后复发模式:微创手术与开腹手术的系统综述与Meta分析

Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis.
PubMed 文献 · Gynecol Oncol · 2021-11-27

该系统综述与Meta分析纳入9项比较不同手术途径的研究、共1663例IB1期宫颈癌根治性子宫切除术患者,复发率为10.6%;开腹与微创手术在局部、远处及两者兼有的复发模式上均无统计学显著差异。

要点

  • 纳入1663例IB1期宫颈癌根治性子宫切除术患者,复发率为10.6%。
  • 开腹与微创手术的局部复发模式比较无统计学显著差异(OR 0.963;95%CI 0.602-1.541;p=0.898)。
  • 远处复发及局部合并远处复发模式比较亦无统计学显著差异。

核心结论

  • 在IB1期宫颈癌以根治性子宫切除术为主要治疗的患者中,不同手术途径间的复发模式无差异。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Cochrane Library、Clinicaltrials.gov和Web of Science,纳入前瞻性或回顾性比较不同手术途径并描述IB1期宫颈癌复发模式或部位的研究,共分析9篇文章、1663例患者。

主要发现

  • 研究检索自2010年1月至2020年10月共获得782条符合条件文献,最终纳入9篇分析1663例IB1期宫颈癌根治性子宫切除术患者。
  • 纳入患者的复发率为10.6%。
  • 开腹手术与微创手术比较局部复发模式无统计学显著差异(OR 0.963;95%CI 0.602-1.541;p=0.898)。
  • 开腹手术与微创手术比较远处复发模式无统计学显著差异(OR 0.788;95%CI 0.467-1.330;p=0.542)。
  • 开腹手术与微创手术比较局部合并远处复发模式无统计学显著差异(OR 0.683;95%CI 0.331-1.407;p=0.630)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After the LACC trial, the SUCCOR study, and other studies, we know that patients who have undergone minimally invasive surgery for cervical cancer have worse outcomes, but today, we do not know if the surgical approach can be a reason to change the pattern of relapses on these patients. We evaluated the relapse pattern in patients with stage IB1 cervical cancer (FIGO, 2009) who underwent radical hysterectomy with different surgical approaches. METHODS: A systematic review of literature was performed in PubMed, Cochrane Library, Clinicaltrials.gov, and Web of science. Inclusion criteria were prospective or retrospective comparative studies of different surgical approaches that described patterns or locations of relapse in patients with stage IB1 cervical cancer. Heterogeneity was assessed by calculating I2. RESULTS: The research resulted in 782 eligible citations from January 2010 to October 2020. After filtering, nine articles that met all inclusion criteria were analyzed, comprising data from 1663 patients who underwent radical hysterectomy for IB1 cervical cancer, and the incidence of relapse was 10.6%. When we compared the pattern of relapse (local, distant, and both) of each group (open surgery and minimally invasive surgery), we did not see statistically significant differences, (OR 0.963; 95% CI, 0.602-1.541; p = 0.898), (OR 0.788; 95% CI, 0.467-1.330; p = 0.542), and (OR 0.683; 95% CI, 0.331-1.407; p = 0.630), respectively. CONCLUSION: There are no differences in patterns of relapse across surgical approaches in patients with stage IB1 cervical cancer undergoing radical hysterectomy as primary treatment.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Manzour N, Núñez-Cordoba JM, Chiva L, et al. Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis. Gynecol Oncol. 2021. PMID: 34848071. doi:10.1016/j.ygyno.2021.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。